Institute for Behavioral Health
Schneider Institutes for Health Policy
The Heller School for Social Policy and Management at Brandeis University
Aiming to increase recognition of the way behaviors impact health, and to work with systems and organizations to design processes and approaches that improve the overall health of the population.
CONSTANCE M. HORGAN, SC.D.
Since the Heller School began, both faculty and students have studied mental and substance use disorders. Formalized in 2003, IBH focuses on the intersection of health, behavior, and systems of care, with an emphasis on their linkages. Its underlying premise is that these systems can be better used to promote healthier lifestyles and assist individuals to engage in behaviors which lead to better health.
Our focus is broadening to include other issues that are affected by behaviors which can be targeted by interventions and have an impact on health and wellness. In addition to studying systems of care, we investigate health outcomes that are associated with behaviors, and also develop and test methods to evaluate the effects of behaviors on health.
We consider a variety of systems of care, including health care delivery, as well as criminal justice, education, social services, housing, military and the workplace.
We hope that you find this site useful as you learn more about our research staff and our activities in behavioral health.
IBH researchers delivered a 90-minute workshop on diversity and equity issues confronting military and veterans' health care as part of the Heller School's 55th anniversary celebration September 13, 2014. Presenters included Dr. Mary Jo Larson (moderator), and panelists Drs. Rachel Sayko Adams, Margot Davis, Norah Mulvaney Day, and Nikki R. Wooten. Background slides.
Researchers at the Institute for Behavioral Health (Mary Jo Larson, PI) have received a $3 million research grant award from NIH’s National Center for Complementary and Alternative Medicine (NIH/NCCAM). The research project is titled, “Longitudinal Study of Post-Deployment CAM Pain Management Using DoD and VA Data.”
Dominic Hodgkin and Cindy Thomas work with researchers at Truven Health Analytics on an investigation of prospects for future emergence of new psychiatric medications. The study examines the pathway and current status of psychotropic drugs in the pipeline (pre-clinical trial to FDA approval).
Institute for Behavioral Health research team of Mary Jo larson, Deborah Garnick, Rachel S. Adams, Ruslan V. Nikitin, and Grant A. Ritter contribute to May 29 Department of Defense Conference Report,"Study on Incidence of Breast Cancer Among Members of Armed Services Serving on Active Duty."
Mary Jo Larson, Senior Scientist at the Institute for Behavioral Health, was a Committee member and co-author of a report released this week by the National Academy of Sciences, Institute of Medicine. Related commentary can be found in articles in the Wall Street Journal and USA Today.
O'Brein PL, Thomas CP, Hodgkin D, Levit KR, Mark TL. The Diminished Pipeline for Medications to Treat Mental Health and Substance Use Disorders. Psychiatric Services, 65(12):1433-1438. PMCID: Journal- in-Process.